Pharmacokinetic study of bortezomib administered intravenously in Taiwanese patients with multiple myeloma-Reference-Cited by-同舟云学术

Pharmacokinetic study of bortezomib administered intravenously in Taiwanese patients with multiple myeloma

Published:2017-06-19 Issue:1 Volume:36 Page:238-244
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematological Oncology

Author:

Huang Shang-Yi¹,Chang Cheng-Shyong²,Liu Ta-Chih³,Wang Po-Nan⁴,Yeh Su-Peng⁵,Ho Ching-Liang⁶,Kuo Ming-Chung⁴,Lin Hsuan-Yu²,de Jong Jan⁷,Chen Jia-Yi⁸,Yang Ya-Wen⁸

Affiliation:

1. Division of Hematology, College of Medicine; National Taiwan University and Hospital; Taipei Taiwan

2. Division of Hematology-Oncology, Department of Internal Medicine; Changhua Christian Hospital; Changhua Taiwan

3. Division of Hematology-Oncology, Department of Internal Medicine; Kaohsiung Medical University Hospital; Kaohsiung Taiwan

4. Chang Gung Memorial Hospital; Linkou Taiwan

5. Division of Hematology and Oncology, Department of Internal Medicine; China Medical University Hospital; Taichung Taiwan

6. Division of Hematology/Oncology, Tri-Service General Hospital; National Defense Medical Center; Taipei Taiwan

7. Janssen Research & Development; San Diego CA USA

8. Janssen Medical Affairs; Taipei Taiwan

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Reference41 articles.

1. Understanding the hypoxic niche of multiple myeloma: therapeutic implications and contributions of mouse models;Hu;Dis Model Mech,2012

2. Multiple myeloma;Raab;Lancet,2009

3. Epidemiology of multiple myeloma in Taiwan: increasing incidence for the past 25 years and higher prevalence of extramedullary myeloma in patients younger than 55 years;Huang;Cancer,2007

4. Emerging therapies for multiple myeloma;Klaus Podar;Expert Opin Emerg Drugs,2009

5. NCCN clinical practice guidelines in oncology: multiple myeloma;Anderson;J Natl Compr Canc Netw,2009

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BRD4 inhibitor nitroxoline enhances the sensitivity of multiple myeloma cells to bortezomib in vitro and in vivo by promoting mitochondrial pathway-mediated cell apoptosis;Therapeutic Advances in Hematology;2020-01

2. The snoRNA target of t(4;14) in multiple myeloma regulates ribosome biogenesis;FASEB BioAdvances;2019-05-22